These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. Soran OZ, Piña IL, Lamas GA, Kelsey SF, Selzer F, Pilotte J, Lave JR, Feldman AM. J Card Fail; 2008 Nov; 14(9):711-7. PubMed ID: 18995174 [Abstract] [Full Text] [Related]
3. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH, TEN-HMS Investigators. J Am Coll Cardiol; 2005 May 17; 45(10):1654-64. PubMed ID: 15893183 [Abstract] [Full Text] [Related]
4. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF Study Group. J Am Coll Cardiol; 2008 Mar 18; 51(11):1073-9. PubMed ID: 18342224 [Abstract] [Full Text] [Related]
8. Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure. Austin J, Williams WR, Ross L, Hutchison S. Eur J Cardiovasc Prev Rehabil; 2008 Apr 18; 15(2):162-7. PubMed ID: 18391642 [Abstract] [Full Text] [Related]
9. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R, FUSION II Investigators. Circ Heart Fail; 2008 May 18; 1(1):9-16. PubMed ID: 19808265 [Abstract] [Full Text] [Related]
10. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals. Arch Intern Med; 2007 Jul 23; 167(14):1493-502. PubMed ID: 17646603 [Abstract] [Full Text] [Related]
11. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Circulation; 2007 Jan 16; 115(2):204-12. PubMed ID: 17190867 [Abstract] [Full Text] [Related]
12. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC. Am Heart J; 2008 Oct 16; 156(4):662-73. PubMed ID: 18926148 [Abstract] [Full Text] [Related]